HPV determination in the control after LEEP due to CIN II-III: Prospective study and predictive model

International Journal of Gynecological Pathology

Volumn 28, Issue 2, 2009, Pages 120-126

  Fuste, Pere ^a   Bellosillo, Bea ^a   Santamaria, Xavier ^a   Mancebo, Gemma ^a   Mariñoso, Leisa ^a   Alameda, Francesc ^a   Espinet, Blanca ^a   Sole, Francese ^a   Serrano, Sergi ^a   Carreras, Ramon ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

CIN; Endocervical cytology; HPV determination; LEEP

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; ELECTROSURGERY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MODEL; NOMOGRAM; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONIZATION; ELECTROSURGERY; FEMALE; HUMANS; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 68949199566     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181891459     Document Type: Article

References (28)

1. Cardenas-Turanzas M, Follen M, Benedet JL, et al. See-and-treat strategy for diagnosis and management of cervical squamous intraepithelial lesions. Lancet Oncol 2005;6:43-50. (Pubitemid 40089718)
2. Kalliala I, Anttila A, Pukkala E, et al. Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ 2005;331:1183-1185 (Pubitemid 41689433)
3. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, et al. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006;367:489-498 (Pubitemid 43208905)
4. Kyrgiou M, Tsoumpou I, Vrekoussis T, et al. The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy & cervical cytopathology collaborative group (C5 group) approach. Cancer Treat Rev 2006;32:516-523 (Pubitemid 44464136)
5. Mitchell MF, Tortolero-Luna G, Cook E, et al. A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix. Obstet Gynecol 1998;92:737-744 (Pubitemid 28487667)
6. Chia K, Scarffe R. Is it efficacious to use large loop excision of the transformation zone for "diagnosis and treatment in one procedure" in the management of cervical intraepithelial neoplasia." J Obstet Gynaecol 1994;14:44-9.
7. Mann CH, Steele JC, Burton A, et al. LLETZ - evidence of its efficacy against HPV infection. Gynecol Oncol 2001;81:125-127
8. Houfflin Debarge V, Collinet P, Vinatier D, et al. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions. Gynecol Oncol 2003;90:587-592
9. Soutter WP, Sasieni P, Panoskaltsis T. Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia. Int J Cancer 2006;118:2048-2055
10. Chao A, Lin CT, Hsueh S, et al. Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization. Am J Obstet Gynecol 2004;190:1046-1051 (Pubitemid 38561522)
11. Lu CH, Liu FS, Kuo CJ, et al. Prediction of persistence or recurrence after conization for cervical intraepithelial neoplasia III. Obstet Gynecol 2006;107:830-835 (Pubitemid 43755581)
12. Cuzick J, Mayrand MH, Ronco G, et al. New dimensions in cervical cancer screening (chapter 10). Vaccine 2006;24(suppl 3):S90-7. (Pubitemid 44293036)
13. Denny L, Quinn M, Sankaranarayanan R. Screening for cervical cancer in developing countries (chapter 8). Vaccine 2006;24(suppl 3):S71-7. (Pubitemid 44293035)
14. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006;24(suppl 1):S1-5.
15. Elfgren K, Bistoletti P, Dillner L, et al. Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens. Am J Obstet Gynecol 1996;174:937-942 (Pubitemid 26111675)
16. Chua KL, Hjerpe A. Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri. Gynecol Oncol 1997;66:108-113 (Pubitemid 27329317)
17. Alonso I, Torne A, Puig-Tintore LM, et al. Pre- and postconization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Gynecol Oncol 2006;103:631-636 (Pubitemid 44602179)
18. Zielinski GD, Bais AG, Helmerhorst TJ, et al. HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis. Obstet Gynecol Surv 2004;59:543-553 (Pubitemid 38802827)
19. Sarian LO, Derchain SF, Andrade LA, et al. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of highg-rade cervical intraepithelial neoplasia. Gynecol Oncol 2004;94:181-186
20. Jain S, Tseng CJ, Horng SG, et al. Negative predictive value of human papillomavirus test following conization of the cervix uteri. Gynecol Oncol 2001;82:177-180 (Pubitemid 32634973)
21. Almog B, Gamzu R, Kuperminc MJ, et al. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia. Gynecol Oncol 2003;88:345-350 (Pubitemid 36331988)
22. Bar-Am A, Gamzu R, Levin I, et al. Follow-up by combined cytology and human papillomavirus testing for patients postcone biopsy: results of a long-term follow-up. Gynecol Oncol 2003;91:149-153 (Pubitemid 37188605)
23. Song SH, Lee JK, Oh MJ, et al. Persistent HPV infection after conization in patients with negative margins. Gynecol Oncol 2006;101:418-422
24. Sarian LO, Derchain SF, Pitta Dda R, et al. Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ). J Clin Virol 2004;31:270-274
25. Frauchiger WL, De Frias DV, Cajulis RS, et al. The immediate postconization endocervical smear: evaluation of its utility in the detection of residual dysplasia. Acta Cytol 1998;42:1139-1143
26. Cirisano FD. Management of pre-invasive disease of the cervix. Semin Surg Oncol 1999;16:222-227
27. Almog B, Gamzu R, Bornstein J, et al. Clinical and economic benefit of HPV-load testing in follow-up and management of women postcone biopsy for CIN2-3. Br J Cancer 2003;89:109-112. (Pubitemid 36897945)
28. Costa S, De Simone P, Venturoli S, et al. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Gynecol Oncol 2003;90:358-365 (Pubitemid 36952027)